Acute anti‐Aβ antibody exposure induces microglial changes and significantly alters chemokine signaling

Abstract INTRODUCTION While the anti‐amyloid‐lowering immunotherapies provide the first disease‐targeting therapies for the treatment of Alzheimer's disease, there remain harmful adverse events causing hesitation among patients, families, physicians, and regulatory bodies. Though these drugs have be...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Kate E. Foley, Erica M. Weekman, Donna M. Wilcock
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Wiley 2026-01-01
Sarja:	Alzheimer’s & Dementia: Translational Research & Clinical Interventions
Aiheet:	anti‐amyloid anti‐Aβ CCL chemokine microglia single‐cell sequencing
Linkit:	https://doi.org/10.1002/trc2.70201
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!